ONO 8055Alternative Names: ONO-8055
Latest Information Update: 26 Apr 2016
At a glance
- Originator Ono Pharmaceutical
- Mechanism of Action Prostaglandin E EP2 receptor agonists; Prostaglandin E EP3 receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Bladder dysfunction
Most Recent Events
- 30 Sep 2012 Phase-I clinical trials in Bladder dysfunction in Europe (PO)